0001140361-24-032163.txt : 20240702 0001140361-24-032163.hdr.sgml : 20240702 20240702163042 ACCESSION NUMBER: 0001140361-24-032163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240628 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GKCC, LLC CENTRAL INDEX KEY: 0001977769 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 241096038 BUSINESS ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: (302) 992-8882 MAIL ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chudnovsky Yekaterina CENTRAL INDEX KEY: 0001979324 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 241096039 MAIL ADDRESS: STREET 1: C/O ELICIO THERAPEUTICS, INC. STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elicio Therapeutics, Inc. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (857) 209-0050 MAIL ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Angion Biomedica Corp. DATE OF NAME CHANGE: 20140228 4 1 form4.xml FORM 4 X0508 4 2024-06-28 0001601485 Elicio Therapeutics, Inc. ELTX 0001979324 Chudnovsky Yekaterina C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true true 0001977769 GKCC, LLC 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 true false Common Warrants 5 2024-06-28 4 P 0 1600000 0 A Common Stock 1600000 1600000 D Pre-Funded Warrants 0.01 2024-06-28 4 P 0 1600000 4.99 A Common Stock 1600000 1600000 D Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%. The Common Warrants expire on July 1, 2029. Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%. The Pre-Funded Warrants do not have an expiration date. /s/ Yekaterina Chudnovsky 2024-07-02 /s/ Yekaterina Chudnovsky, Manager GKCC, LLC 2024-07-02